Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Activating TRPV3 stops human hair growth.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Birds can lose neck feathers due to a genetic change that increases a gene's activity, helping them adapt to heat.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Myc changes chromatin in stem cells, causing them to leave their niche.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

EGF makes hair follicles grow longer but stops hair production.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Mutant mice help researchers understand hair growth and related genetic factors.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Skin problems are very common in people with end-stage kidney disease.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

NIR light therapy may effectively treat eye diseases and improve brain function without side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Testosterone may slow down wound healing and increase inflammation.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.